A 40-year-old female with a 20-year history of recurrent PSVT presented with a 3-h history of fast, regular palpitations of abrupt onset. Previous episodes had resolved spontaneously or with vagotonic manoeuvres, although adenosine (12 mg) had been required on one occasion in the previous year. Medications on admission were sotalol (40 mg twice daily), L-thyroxine (250 mg once daily) for hypothyroidism following Hashimoto's thyroiditis and prednisolone (5 mg once daily) with hydroxychloroquine (200 mg twice daily) for systemic lupus erythematosus. Previous electrocardiograms (ECGs) in sinus rhythm were normal with no evidence of pre-excitation and a normal QT interval. The heart rate was 160 beats min-' and the blood pressure was 85/60 mmHg. The physical examination was otherwise unremarkable. A 12-lead ECG demonstrated a regular narrow-complex tachycardia conducted with right bundle branch block morphology. Vagotonic manoeuvres were unhelpful and, therefore, adenosine was administered as a 3-mgh followed by a 6-mg intravenous bolus. A continuous lead 11 rhythm strip of the events which followed the 6-mg bolus is shown ( Fig. 1 ). Thirteen seconds after injection, four beats of non-sustained broad-complex tachycardia (suggestive of VT) were observed followed by a period of electrical instability over the next 12 s. Sinus rhythm was restored without further complication and a subsequent 12-lead ECG was normal. Plasma electrolytes, cardiac enzymes and the results of thyroid function tests were normal. Transthoracic echocardiography was also normal but an electrophysiological study demonstrated the presence of a retrograde partial AV nodal bypass tract which was treated by catheter radiofrequency ablation.
DISCUSSION
With only a single-lead ECG recording it is not possible to unequivocally diagnose the non-sustained broad-complex tachycardia as ventricular tachycardia, the other possibility being acceleration of the re-entrant tachycardia with aberrant conduction. Nevertheless, two previous reports of serious ventricular arrhythmias (torsades de pointes in a patient with a long QT interval2 and non-sustained polymorphic VT3) suggest that these are an occasional adverse effect of adenosine injection. The Committee on Safety of Medicines has received four other reports of ventricular arrhythmia following adenosine: one of torsades de pointes leading to ventricular fibrillation, one of ventricular ectopics and two of ventricular tachycardia (Committee on Safety of Medicines, personal communication). Other tachyarrhythmias including delayed sinus tachycardia, ventricular extrasystoles4 and a paradoxical enhancement of AV nodal conduction5 have also been observed. Adenosine has a number of electrophy-Adenosine-induced tachycardia Vagotonic procedures (including the Valsalva manoeuvre, carotid sinus massage and cold water head immersion) remain the first-line treatment for paroxysmal re-entrant supraventricular tachycardias in the accident and emergency department. If these fail, adenosine should be administered but with continuous ECG monitoring and with the facilities for direct current cardioversion available. Clinicians should be alert to the possibility of tachy-as well as bradyarrhythmias following adenosine injection.
